Natera specializes in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology through a cell-free DNA (cfDNA) technology platform approach.
Timeline
April 2015
Natera raises a $55,500,000 series F round from Franklin Templeton Investments, HealthCor Partners, Jennison Associates, OrbiMed, RA Capital Management, Sequoia Capital and Sofinnova Investments.
May 2013
Natera raises a $54,600,000 series E round from Claremont Creek Ventures, Founders Fund, Harmony Partners, Lightspeed Venture Partners, OrbiMed and Sequoia Capital.
January 6, 2012
Natera raises a $20,000,000 series D round from Claremont Creek Ventures, Lightspeed Venture Partners and Sequoia Capital.
April 2011
Natera raises a $2,000,000 grant from National Institutes of Health.
November 2010
Natera raises a $12,000,000 series C round from Sequoia Capital.
January 2009
Natera raises a $6,000,000 series B round from Alafi Capital, Claremont Creek Ventures and Sequoia Capital.
December 2008
Natera raises a $4,000,000 series A round from Claremont Creek Ventures and Sequoia Capital.
2007
Natera was founded by Jonathan Sheena and Matthew Rabinowitz.
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
55,500,000
April 2015
54,600,000
May 2013
20,000,000
January 6, 2012
6,000,000
January 2009
4,000,000
December 2008
People
Name
Role
LinkedIn
Agnes Fajardo
Employee
Agust Egilsson
Employee
AJ Errickson
Employee
Akshita Kalyan
Employee
Alana Anderson
Employee
Alana Turangan
Employee
Albert Chan, MD
Advisor
Alex Wong
Employee
Alfred Haddad
Employee
Amanda Yang
Employee
Amy Johnson
Employee
Andrew Anfora
Employee
Andy Shinn
Employee
Angela Chu
Employee
Ann-Marie Soto
Employee
Annabelle Tang
Employee
Archana Dorge
Employee
Audrey Mark
Employee
Bobbi Ratley
Employee
Brandon Nguyen
Employee
Brandon Rader
Employee
Brian Johnson
Employee
Bronwyn Barnett
Employee
Caroline Kelly
Employee
Catherine Medina
Employee
Page 1 of 5
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Natera, Inc.
May 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present 4 posters at the 2021...
Natera, Inc.
April 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first...
April 22, 2021
BioSpace
ProsperaTM Transplant Assessment Test: Path Established to Expand Future Coverage to Multiple Organs - read this article along with other careers information, tips and advice on BioSpace
Natera, Inc.
April 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and a global leader in cell-free DNA testing, receives pathway to future coverage for the Prospera...
Natera, Inc.
February 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior...
Natera, Inc.
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual...
Natera, Inc.
January 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed a lawsuit today against Inivata, Ltd. and its...
Natera, Inc.
January 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the...
Natera, Inc.
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized...
Natera, Inc.
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at...
Natera, Inc.
December 18, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office...
Natera, Inc.
December 3, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health...
Natera, Inc.
November 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced a new paper published in Annals of Oncology,...
BioSpace
November 19, 2020
BioSpace
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors.
Natera, Inc.
November 10, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new immunotherapy data on...
BioSpace
June 1, 2020
BioSpace
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, is pleased to announce the launch of a novel technique to enhance results from the Prospera donor-derived cell-free DNA (dd-cfDNA) transplant reject
Natera
May 6, 2019
www.prnewswire.com:443
SAN CARLOS, Calif., May 6, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Natera
April 16, 2019
www.prnewswire.com:443
SAN CARLOS, Calif., April 16, 2019 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a...
References
Is a
Company attributes
Company status
Active
B2X
Crunchbase
Pitchbook
Legal name
Natera, Inc.
Legal classification
Date incorporated
2007
Number of Employees (ranges)
5,000–9,999
Full address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
CIK number
Founded date
2004
Total funding amount (USD)
404,100,000
Latest funding round date
April 2020
Stock symbol
NTRA
Stock exchange
Former CEO
Latest funding type
Categories
Related Topics
Contributors
- 1
Blessing Nwodo
Experienced writer - 2
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 3
Bhupendra Solanki
Researcher - 4
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 5
Amit Gehlot
Influencer + Btech from RTU, Surfing on Internet. I like to learn new things + Travel + Foody. - 6
Aime Anne Nisay
QA Engineer of web and mobile applications - 7
Melanie Manipula
Helping organize knowledge. - 8
Arjun Singh
Researcher - 9
Dushyant Soni
Researcher
